From the Chief Financial Officer: A message about travel
June 9, 2021
As previously communicated by President Henrich, planning can begin for business travel occurring on or after July 1, 2021. Travel policies and procedures as defined by the Handbook of Operating Procedures (HOP) 6.2 remain in place. As a reminder, international business trips must be registered and overseas business travel to high-risk areas requires review and approval by the International Oversight Committee (IOC) in accordance with HOP 15.2 and UT System Policy 190.
Bexar County Medical Society Magazine: The COVID-19 Graduate Medical Education Pandemic Response: Innovation, Agility and Collaboration
June 9, 2021
An article about UT Health San Antonio’s COVID-19 deployment featuring our Graduate Medical Education faculty is included in the Bexar County Medical Society Magazine. Read the story.
KSAT 12: Is there a time limit to get your second Pfizer or Moderna shot?
June 9, 2021
Dr. Ruth Berggren, Infectious Diseases/Center for Medical Humanities and Ethics, participated in a KSAT 12 news story on the question of a time limit for getting the second Pfizer or Moderna shot, even if you are past the 21- or 28-day limit for second …
Fox 29: UT Health San Antonio researchers discover how COVID can hide in the body
June 9, 2021
Dr. Yogesh Gupta,Biochemistry/Structural Biology/Greehey Children’s Cancer Research Institute, spoke to Fox 29 news audiences on the topic of the recent published findings in Nature Communications about the COVID-19 virus using metal ions, like magnesi …
Media advisory: Experts from Glenn Biggs Institute at UT Health San Antonio available to discuss new Alzheimer’s drug
June 9, 2021
The U.S. Food and Drug Administration (FDA) on Monday, June 7, approved the drug aducanumab for the treatment of Alzheimer’s disease, which affects 6.2 million Americans. Sudha Seshadri, MD, professor of neurology at UT Health San Antonio and director of the university’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, issued the following statement: “We are excited that a drug, aducanumab (Aduhelm, from Biogen), has been approved by the FDA for treatment of persons with early symptoms due to Alzheimer’s disease. This is the first new drug approved for Alzheimer’s in two decades.”
Texas Public Radio: An expert answers teens’ questions about the Pfizer vaccine
June 8, 2021
Dr. Barbara Taylor, Infectious Diseases, answered several Pfizer-vaccine questions during this Texas Public Radio podcast hosted by Bonnie Petrie, following Petrie’s interview of her own 15-year-old daughter, Aidan, who received her first dose of the P …
AAMC: Medical burnout: Breaking bad
June 8, 2021
Dr. Dharam Kaushik, Urology, accepted AAMC Managing Editor Gabrielle Redford’s challenge to expand his original piece, published in Lancet EClinicalMedicine, adding action points regarding the burnout suffered by health care workers. Read the story.
Texas Public Radio: San Antonio scientists uncover one way the COVID-19 virus hides from the immune system
June 8, 2021
Dr. Yogesh Gupta, Biochemistry/Structural Biology/Greehey Children’s Cancer Research Institute, spoke to Texas Public Radio’s Bonnie Petrie about recent published findings in Nature Communications about the COVID-19 virus using metal ions, like magnesi …
Texas Standard: Metal ions and COVID-19
June 8, 2021
Dr. Yogesh Gupta, Biochemistry/Structural Biology/Greehey Children’s Cancer Research Institute, spoke to Texas Public Radio’s Bonnie Petrie and that program was repeated for broadcast by the Texas Standard. The topic centered on the recent published fi …
UT Health San Antonio to provide student health services at UTSA
June 7, 2021
UT Health San Antonio will provide clinical services for students that include primary care, women’s health and behavioral health services through the School of Nursing’s Wellness 360 clinical practice.